Top Markets
Coin of the day
Chi Sheng Pharma & Biotech Co., Ltd Chi Sheng Pharma & Biotech Co., Ltd

Chi Sheng Pharma & Biotech Co., Ltd

4111
Rang in Aktien #24730
Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged... Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged in the development, production, distribution, and international trade of a diverse range of products. Operating across both domestic and global markets, the company specializes in pharmaceuticals, medical products, cosmetics, health foods, and medical equipment. Its extensive product portfolio covers numerous therapeutic categories, including antibiotics, chemotherapeutic agents, plasma substitutes, amino acid preparations, water nutrients, electrolyte solutions, and vitamins. Additionally, the company provides hepatotropic agents, hormones, adrenal cortical steroids, autonomic nerve agents, antihistamines, antipruritics, antipyretics, analgesics, antitussives, anti-asthmatics, gastro-intestinal preparations, and local anesthetic solutions. Further extending its offerings, Chi Sheng Pharma & Biotech supplies hemodialysis concentrates, peritoneal dialysis solutions, and various other specialized medical items. Beyond medicinal products, the company provides medical devices, fat emulsion products, anesthetics, hemostatic solutions, food products, functional beverages, skincare items, and veterinary medicines. It also offers external solutions such as those for contact lenses, saline, and iodine. The company was founded in 1962 and maintains its headquarters in Hsinchu, Taiwan.
Aktienkurs
$0.95874069
Marktkapitalisierung
$57.36M
Veränderung (1 Tag)
0.33%
Veränderung (1 Jahr)
-9.21%
Land
TW
Handel Chi Sheng Pharma & Biotech Co., Ltd (4111)

Kategorie

P/S-Verhältnis für Chi Sheng Pharma & Biotech Co., Ltd (4111)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Chi Sheng Pharma & Biotech Co., Ltd beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Chi Sheng Pharma & Biotech Co., Ltd von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
12.63 -
US
2.55 -
FR
- -
JP
2.43 -
US
- -
CH